These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
470 related items for PubMed ID: 28050782
1. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Jewel Samadder N, Valentine JF, Guthery S, Singh H, Bernstein CN, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich CM, Burt RW, Curtin K, Smith KR. Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782 [Abstract] [Full Text] [Related]
2. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008). Peyrin-Biroulet L, Lepage C, Jooste V, Guéant JL, Faivre J, Bouvier AM. Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511 [Abstract] [Full Text] [Related]
3. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Samadder NJ, Valentine JF, Guthery S, Singh H, Bernstein CN, Leighton JA, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Burt RW, Curtin K, Smith KR. Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862 [Abstract] [Full Text] [Related]
5. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Ording AG, Horváth-Puhó E, Erichsen R, Long MD, Baron JA, Lash TL, Sørensen HT. Inflamm Bowel Dis; 2013 Mar; 19(4):800-5. PubMed ID: 23435402 [Abstract] [Full Text] [Related]
6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Scand J Gastroenterol; 2009 Mar; 44(1):46-55. PubMed ID: 18609187 [Abstract] [Full Text] [Related]
7. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [Abstract] [Full Text] [Related]
8. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study. Birch RJ, Burr N, Subramanian V, Tiernan JP, Hull MA, Finan P, Rose A, Rutter M, Valori R, Downing A, Morris EJA. Am J Gastroenterol; 2022 Nov 01; 117(11):1858-1870. PubMed ID: 36327438 [Abstract] [Full Text] [Related]
9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients]. Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL. Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026 [Abstract] [Full Text] [Related]
10. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D, Rowe KG, Mineau GP, Smith K, Pimentel R, Kirchhoff AC, Burt RW. Gastroenterology; 2014 Apr 29; 146(4):950-60. PubMed ID: 24417818 [Abstract] [Full Text] [Related]
11. The epidemiology of inflammatory bowel disease. Burisch J, Munkholm P. Scand J Gastroenterol; 2015 Aug 29; 50(8):942-51. PubMed ID: 25687629 [Abstract] [Full Text] [Related]
12. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? Dyson JK, Rutter MD. World J Gastroenterol; 2012 Aug 07; 18(29):3839-48. PubMed ID: 22876036 [Abstract] [Full Text] [Related]
13. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. Baars JE, Kuipers EJ, van Haastert M, Nicolaï JJ, Poen AC, van der Woude CJ. J Gastroenterol; 2012 Dec 07; 47(12):1308-22. PubMed ID: 22627504 [Abstract] [Full Text] [Related]
14. Carcinogenesis in inflammatory bowel disease. Herszenyi L, Miheller P, Tulassay Z. Dig Dis; 2007 Dec 07; 25(3):267-9. PubMed ID: 17827953 [Abstract] [Full Text] [Related]
15. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Bernstein CN, Nugent Z, Blanchard JF. Am J Gastroenterol; 2011 Apr 07; 106(4):731-6. PubMed ID: 21407180 [Abstract] [Full Text] [Related]
16. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study. Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF. Lancet Gastroenterol Hepatol; 2020 May 07; 5(5):475-484. PubMed ID: 32066530 [Abstract] [Full Text] [Related]
17. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Inflamm Bowel Dis; 2013 May 07; 19(4):789-99. PubMed ID: 23448792 [Abstract] [Full Text] [Related]
18. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study. Everhov ÅH, Erichsen R, Järås J, Pedersen L, Halfvarson J, Askling J, Ekbom A, Ludvigsson JF, Sørensen HT, Olén O. Aliment Pharmacol Ther; 2022 Oct 07; 56(7):1168-1182. PubMed ID: 35916190 [Abstract] [Full Text] [Related]
19. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis. Lindström L, Lapidus A, Ost A, Bergquist A. Dis Colon Rectum; 2011 Nov 07; 54(11):1392-7. PubMed ID: 21979184 [Abstract] [Full Text] [Related]
20. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyöty M, Nieminen I, Hemminki H, Collin P. J Crohns Colitis; 2013 Dec 07; 7(11):e551-7. PubMed ID: 23619008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]